These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28088112)

  • 1. A current perspective on the oncopreventive and oncolytic properties of selective serotonin reuptake inhibitors.
    Radin DP; Patel P
    Biomed Pharmacother; 2017 Mar; 87():636-639. PubMed ID: 28088112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Psychotropic: Potential Repurposing of Fluoxetine toward Cancer Therapy.
    Kadasah SF; Alqahtani AMS; Alkhammash A; Radwan MO
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.
    Isaac R; Boura-Halfon S; Gurevitch D; Shainskaya A; Levkovitz Y; Zick Y
    J Biol Chem; 2013 Feb; 288(8):5682-93. PubMed ID: 23275337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells.
    Kuwahara J; Yamada T; Egashira N; Ueda M; Zukeyama N; Ushio S; Masuda S
    Biol Pharm Bull; 2015; 38(9):1410-4. PubMed ID: 26328498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?
    Schuster C; Fernbach N; Rix U; Superti-Furga G; Holy M; Freissmuth M; Sitte HH; Sexl V
    Biochem Pharmacol; 2007 Nov; 74(9):1424-35. PubMed ID: 17709099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.
    Serafeim A; Holder MJ; Grafton G; Chamba A; Drayson MT; Luong QT; Bunce CM; Gregory CD; Barnes NM; Gordon J
    Blood; 2003 Apr; 101(8):3212-9. PubMed ID: 12515726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Properties of Ampakines
    Radin DP; Purcell R; Lippa AS
    Anticancer Res; 2018 Jan; 38(1):265-269. PubMed ID: 29277782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing SSRIs' effects on fetal cardiomyocytes utilizing placenta-fetus model.
    Arumugasaamy N; Hurley-Novatny A; Lembong J; Kim PCW; Fisher JP
    Acta Biomater; 2019 Nov; 99():258-268. PubMed ID: 31536839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract.
    Caraci F; Crupi R; Drago F; Spina E
    Curr Drug Metab; 2011 Jul; 12(6):570-7. PubMed ID: 21395523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of Selective Serotonin Reuptake Inhibitors with β-Amyloid.
    Tin G; Mohamed T; Shakeri A; Pham AT; Rao PPN
    ACS Chem Neurosci; 2019 Jan; 10(1):226-234. PubMed ID: 30157623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
    Ahrold TK; Meston CM
    J Sex Marital Ther; 2009; 35(4):311-9. PubMed ID: 19466669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.
    Vaswani M; Linda FK; Ramesh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):85-102. PubMed ID: 12551730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
    Carrasco JL; Sandner C
    Int J Clin Pract; 2005 Dec; 59(12):1428-34. PubMed ID: 16351675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of selective serotonin reuptake inhibitors.
    Kroeze Y; Zhou H; Homberg JR
    Pharmacol Ther; 2012 Dec; 136(3):375-400. PubMed ID: 22944042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.
    Ishima T; Fujita Y; Hashimoto K
    Eur J Pharmacol; 2014 Mar; 727():167-73. PubMed ID: 24508523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
    van Harten J
    Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.